Curis
CRIS
#11033
Rank
S$7.75 M
Marketcap
S$1.16
Share price
6.65%
Change (1 day)
-31.86%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2023 (TTM): S-$13.67

According to Curis's latest financial reports the company's current EPS (TTM) is S-$18.22. In 2022 the company made an earnings per share (EPS) of S-$15.63 a decrease over its 2021 EPS that were of S-$12.81.

EPS history for Curis from 2001 to 2023

Annual EPS

Year EPS Change
2023 (TTM)S-$13.67-12.53%
2022S-$15.6322%
2021S-$12.81-25.37%
2020S-$17.17-30.93%
2019S-$24.86-2.02%
2018S-$25.37-37.38%
2017S-$40.52-29.73%
2016S-$57.66-10%
2015S-$64.07138.1%
2014S-$26.9140%
2013S-$19.22-25%
2012S-$25.6366.67%
2011S-$15.38-850%
2010S$2.05-114.29%
2009S-$14.35-26.07%
2008S-$19.41-26.28%
2007S-$26.338.44%
2006S-$24.28-32.68%
2005S-$36.07-3.76%
2004S-$37.4862.95%
2003S-$23.00-93.86%
2002S-$374.4739.5%
2001S-$268.44

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
S$0.97-105.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$5.79-131.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
S-$0.46-97.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
S$4.43-124.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
S-$5.57-69.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
S-$4.07-77.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
S-$4.41-75.81%๐Ÿ‡บ๐Ÿ‡ธ USA